Generics

Christine Baeder, senior vice president and chief operating officer for U.S. generics, Teva Pharmaceuticals USA is the 2023 AAM chair of the board.

Generic Latuda is used to treat a depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients as monotherapy.

An aging population combined with increasing numbers of people diagnosed with chronic diseases are among the top factors set to influence innovation in the generics drug market in 2023.

Alembic’s desonide cream 0.05% is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatosis.

Paclitaxel injection solution is indicated for several different types of cancer.

Denosumab is indicated for treating variety of conditions, such as osteoporosis in postmenopausal women.

Teva will pay Florida $6.73 million, and the state will dismiss all of its claims against the company and its affiliates once payment has been made.

DETAF would be used for the management of HIV infections and will be available for low- and middle-income countries.